
The study explores the relationship between adiponectin, obesity, and hypertension, addressing the "adiponectin paradox." Serum adiponectin levels were lower in obesity-related hypertension cases and inversely correlated with the visceral adiposity index. Gender, serum albumin, alanine aminotransferase, and high-density lipoprotein cholesterol were significant correlates. Adiponectin's role in obesity hypertension involves complex interactions influenced by metabolic homeostasis signaling. Compensatory effects, adiponectin resistance, and impaired clearance contribute to the paradox.
Like
Save
Share